Food and Drug Administration, Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; Fax 301-827-6870 [E-mail Us]

DOCKETS ENTERED on November 27, 2001

TABLE OF CONTENTS

Hyper links are part of the Docket  title - not all dockets/documents are linked

NOTE:  Documents received by the Dockets Management Branch "MAY" be posted on the Internet.

PLEASE DO NOT  include personal identifying information, i.e. date of birth, social security number, etc., in your correspondence.

[FDA DOCKETS PAGE] [FDA HOME PAGE]  [ ITEM CODES ]
 
93P-0310 White Chocolate Deviating From Identity Standard; TPMT *
98D-0997 Metered dose Inhaler and Dry Powder Inhaler Drug Products *
99P-5198 Request amendment of the definition of milk *
00N-1396 Bioengineered Foods Consumed By Humans or Animals *
00P-1276 Health Claim: Plant stanol esters and heart disease *
01D-0195 The Leaveraging Handbook, An Agency Resource for eff Collabo *
01D-0220 Biological Prod Deviation Reporting for Blood & Plasma Estab *
01D-0269 Clinical Studies Section for Prescription Drugs & Biologics *
01D-0361 Guidance ICH Q1D Bracketing and Matrixing Designs for Stabil *
01N-0196 Phenylpropanolamine proposal to withdraw approval of NDA *
01N-0397 Transportation Safety & Potentially Sedating or Impairing *
01N-0402 Third-Party Submissions review/quality system inspections *
01N-0423 Substances Prohibited from use in animal food/Feed Ruminant *
01N-0437 New Animal Drugs for Investigational *
01N-0450 Prescription Drug User Fee Act (PDUFA) *
01P-0250 Dissemination of Non-Misleading Information/Off-Label Uses *
01P-0471 Issue the NFR Placement of Anthrax Vaccine as Category II *
01P-0529 Request that '365 Patent Not be Re-listed in Orange Book *
77N-0085 Saccharin and Its Salts

CA 17879 Don & Sharon Carter Vol#: 402

CA 17941 D. W. Helling Vol#: 403

CA 17969 R. L. Irvin Vol#: 403

CA 18015 John C. Webb Vol#: 403

CA 18281 Jon Ohman Vol#: 407

CA 18308 Emil Hein Vol#: 407

93P-0310 White Chocolate Deviating From Identity Standard; TPMT

LET 99 Parmalat Canada Bakery Division Vol#: 2

98D-0997 Metered dose Inhaler and Dry Powder Inhaler Drug Products

C 29 IPAC-RS Vol#: 4

99D-1454 Nasal spray, inhalation solution, suspension&spray drug prod

C 21 IPAC-RS Vol#: 2

99D-2405 Information Request and Discipline Review Letter

GDL 2 Guideline Vol#: 1

NAD 2 Vol#: 1

99P-5198 Request amendment of the definition of milk

ANS 2 HF-40 to Minnesota Farmers Union Vol#: 1

00N-1396 Bioengineered Foods Consumed By Humans or Animals

C 9146 Mary Ellen Norpel Vol#: 401

C 9147 Fay Gougakis Vol#: 401

00P-0586 Amend Pt 133.3 re:Milk and Nonfat Milk for use in Standardiz

ANS 2 HF-40 to Minnesota Farmers Union Vol#: 2

00P-1275 Health Claim: Vegetable oil sterol esters & coronary heart d

C 21 Keller & Heckman Vol#: 18

C 22 Unilever Bestfoods North America Vol#: 18

C 23 Archer Daniels Midland Company Vol#: 18

C 24 Forbes Medi-Tech Vol#: 18

00P-1276 Health Claim: Plant stanol esters and heart disease

C 24 Keller & Heckman Vol#: 18

C 25 Unilever Bestfoods North America Vol#: 18

C 26 Forbes Medi-Tech Vol#: 18

C 27 Archer Daniels Midland Company Vol#: 18

EC 1 American Heart Association Vol#: 18

01D-0195 The Leaveraging Handbook, An Agency Resource for eff Collabo

EC 1 Edix, Inc Vol#: 1

01D-0220 Biological Prod Deviation Reporting for Blood & Plasma Estab

C 8 San Diego Blood Bank Vol#: 1

C 9 Puget Sound Blood Center Vol#: 1

01D-0269 Clinical Studies Section for Prescription Drugs & Biologics

C 7 Bristol-Myers Squibb Pharm. Res Institut Vol#: 1

01D-0361 Guidance ICH Q1D Bracketing and Matrixing Designs for Stabil

C 2 Abbott Laboratories Vol#: 1

C 3 Merck & Co., Inc. Vol#: 1

01N-0174 Agency Information Collection Recall Regulations

N 2 Vol#: 1

01N-0196 Phenylpropanolamine proposal to withdraw approval of NDA

C 9 Novartis Consumer Health, Inc. Vol#: 1

01N-0256 Use of Opiate Analgesics in Various Patient Population inclu

EC 199 Home Vol#: 4

EC 200 Endometriosis Research Center Vol#: 4

01N-0397 Transportation Safety & Potentially Sedating or Impairing

C 4 Thomas N. Tiedt, Ph.D. Vol#: 2

C 5 Bensinger, DuPont & Associates Vol#: 1

EC 3 Mrs. Sharon Sember Vol#: 2

01N-0402 Third-Party Submissions review/quality system inspections

EC 2 Ms. Lisa Long Vol#: 1

01N-0423 Substances Prohibited from use in animal food/Feed Ruminant

CH 21 Vantage Point Holsteins Inc. Vol#: 5

CH 22 Vic Edgerton Vol#: 5

CH 23 T. K. Eick Vol#: 5

CH 24 Linda K. F. Vesper Vol#: 5

CH 25 National By-Products, Inc. Vol#: 5

CH 26 Pennsylvania Department of Agriculture Vol#: 5

CH 27 Micro Tracers, Inc. Vol#: 5

CH 28 CSPI Vol#: 5

CH 29 State of North Carolina's Vol#: 5

CH 30 National Grain and Feed Association Vol#: 5

CH 31 National Cattlemen's Beef Association Vol#: 5

CH 32 Association of American Railroad Vol#: 5

CH 33 National Milk Producers Federation Vol#: 5

TS 16 University of Berne/Switzerland Vol#: 5

TS 17 H.J. Bakerk & Bro., Inc. Vol#: 5

01N-0437 New Animal Drugs for Investigational

EC 1 Mr. zia zahiri Vol#: 1

01N-0450 Prescription Drug User Fee Act (PDUFA)

EAPE1 Aventis Pharmaceuticals Vol#: 1

EAPE2 Elan Corporation Vol#: 1

EAPE3 Food & Drug Administration Vol#: 1

EAPE4 FDC Reports Vol#: 1

EAPE5 Dow Jones Newswires Vol#: 1

EAPE6 Oracle Partners Vol#: 1

EAPE7 Bristol-Myers Squibb Vol#: 1

EAPE8 Schwab Washington Research Group Vol#: 1

EAPE9 FDA/CDER Vol#: 1

EAPE10 Natl. Organization for Rare Disorders Vol#: 1

EAPE11 Schering-Plough Vol#: 1

EAPE12 PDA Vol#: 1

EAPE13 Pharmacia Corporation Vol#: 1

EAPE14 Wyeth-Ayerst Pharmaceuticals Vol#: 1

EAPE15 Immunex Corporation Vol#: 1

EAPE16 Merrill lynch Vol#: 1

EAPE17 Congressional Research Service Vol#: 1

EAPE18 Novartis Pharmaceuticals Corp. Vol#: 1

EAPE19 Novartis Pharmaceuticals Vol#: 1

EAPE20 Pfizer Inc Vol#: 1

EC 1 Number Not Used Vol#: 1

01N-0459 Food Labeling; Notification Procedures on Dietary Supplement

EC 3 --------- Vol#: 1

01P-0250 Dissemination of Non-Misleading Information/Off-Label Uses

LET 1 HF-11 to Washington Legal Foundation Vol#: 1

01P-0471 Issue the NFR Placement of Anthrax Vaccine as Category II

EMC 13 Richard G. Shuster Vol#: 1

EMC 14 Gretchen Whitney Vol#: 1

EMC 15 John F. Sorg Vol#: 1

EMC 16 Gerald Bozarth Vol#: 1

EMC 17 Meryl Nass, MD Vol#: 1

EMC 18 Jeffrey N. Jeffords Vol#: 1

EMC 19 Jim Daniel Vol#: 1

EMC 20 Bruce & Sara-Lee Beller Vol#: 1

EMC 21 Michael McDermott Vol#: 1

EMC 22 Kevin R. Harkness Vol#: 1

EMC 23 Teresa & Ken Jones Vol#: 1

EMC 24 Teresa & Ken Jones Vol#: 1

EMC 25 Christine L. Lincoln Vol#: 1

EMC 26 Ralph Bell Vol#: 1

EMC 27 Eligible Vol#: 1

EMC 28 Richard G. Shuster Vol#: 1

EMC 29 Theresa Harmon Vol#: 1

01P-0529 Request that '365 Patent Not be Re-listed in Orange Book

ACK 1 HFA-305 Vol#: 1

CP 1 Mylan Pharmaceuticals, Inc. Vol#: 1